Diurnal variations in the plasma concentrations of mevalonic acid in patients with abetalipoproteinaemia
- 1 October 1994
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 24 (10), 698-702
- https://doi.org/10.1111/j.1365-2362.1994.tb01063.x
Abstract
Previous studies have demonstrated that changes in the rates of cholesterol biosynthesis can be evaluated by the determination of plasma concentrations of sterol intermediates, including mevalonic acid and lathosterol and that, in normal human subjects, a diurnal rhythm exists in which the highest concentrations of sterol intermediates are observed at night. The factors responsible for this diurnal rhythm in cholesterol synthesis are, however, unknown. To test the hypothesis that the nocturnal increase in cholesterol biosynthesis is attributable to a reduced rate of hepatic uptake of chylomicron remnants at night as compared to higher rates of uptake during the daytime in response to alimentary lipaemia, we have examined the diurnal rhythm of mevalonic acid in six normal volunteers and three patients with phenotypic abetalipoproteinaemia. The latter patients do not absorb appreciable amounts of dietary cholesterol and are unable to synthesize chylomicron particles. Plasma concentrations of mevalonic acid exhibited a diurnal rhythm in the normal subjects, and the highest plasma concentrations were observed between 24.00 hours/04.00 hours. A similar rhythm was observed in the plasma of patients with abetalipoproteinaemia. These results suggest that the nocturnal increase in cholesterol biosynthesis which occurs in humans is not attributable to reduced hepatic uptake of chylomicron remnants at night; further studies are needed to better define those factors which influence the periodicity of cholesterol biosynthesis in humans.Keywords
This publication has 29 references indexed in Scilit:
- Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesisEuropean Journal of Clinical Investigation, 1992
- Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemiaMetabolism, 1989
- Increased urinary mevalonic acid excretion in patients with abetalipoproteinemia and homozygous hypobetalipoproteinemiaAtherosclerosis, 1989
- Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic eventsDiabetes, 1989
- Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man.Journal of Clinical Investigation, 1988
- Binding of low-density lipoprotein and chylomicron remnants to the hepatic low-density lipoprotein receptor of dogs, rats and rabbits demonstrated by ligand blotting. Failure to detect a distinct chylomicron-remnant-binding protein by ligand blottingEuropean Journal of Biochemistry, 1986
- ProlactinNew England Journal of Medicine, 1978
- Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjectsClinica Chimica Acta; International Journal of Clinical Chemistry, 1974
- Rhythmic changes of hydroxymethylglutaryl coenzyme a reductase activity in livers of fed and fasted ratsFEBS Letters, 1969
- Turnover of plasma cholesterol in manJournal of Clinical Investigation, 1968